New Alzheimer’s Drugs May Not Be the Breakthrough Families Hoped For – So What Can You Do Now?
For families supporting an older loved one with memory problems, news about new Alzheimer’s treatments can bring both hope and confusion.
Many people have been following reports about so-called “breakthrough” anti-amyloid drugs — medicines designed to remove amyloid plaque from the brain, which has long been associated with Alzheimer’s disease.
But a major new review suggests these drugs may not deliver the meaningful improvements families have been hoping for.
What the new research says
A large review by the respected research organisation Cochrane looked at 17 clinical trials involving more than 20,000 people.
The conclusion was stark:
The absolute effects of anti-amyloid drugs on cognitive decline and dementia severity were absent or trivial…
In simple terms, while some studies showed small statistical changes, the improvements were often too small to make a noticeable difference in day-to-day life.
That means families may not see meaningful changes in things like:
- memory
- confusion
- independence
- communication
- daily functioning
Francesco Nonino, neurologist and epidemiologist at the IRCCS Institute of Neurological Sciences of Bologna, explained that although some early results looked promising on paper, they may not be clinically relevant in real life.
For families, this can be disappointing and frustrating.
Why this matters to families
When someone you love is experiencing cognitive decline, every month matters.
Families often invest emotionally in headlines about “new treatments” and may feel devastated when those hopes are not realised.
These drugs have also involved years of global investment by pharmaceutical companies, governments and charities – reflecting the urgent need to find answers.
But researchers are increasingly questioning whether amyloid is the true cause of Alzheimer’s, or simply a by-product of the disease process.
If amyloid is a downstream effect, then removing it may not stop the disease progressing.
This raises questions about whether people should continue entering more anti-amyloid drug trials.
“Anti-amyloid trials raise important scientific and ethical questions”, says David Smith Emeritus Professor of Pharmacology from the University of Oxford and member of the Scientific Advisory Board of foodforthebrain.org, a research and education charity focused on the prevention of Alzheimer’s and supporting mental health. “Is it justifiable to ask patients to undergo yet more trials of anti-amyloid treatments?” he asks.
The good news: prevention and lifestyle may help
While the drug news may feel discouraging, there is another side to the story.
A growing body of evidence suggests that prevention and lifestyle interventions may help reduce risk or slow early decline.
Researchers are increasingly looking at factors such as:
- nutrition
- sleep
- blood sugar balance
- stress
- exercise
- gut health
- inflammation
- vitamin deficiencies
Some studies suggest that correcting low levels of:
- B vitamins
- omega-3 fatty acids
may help some people with early cognitive decline.
These approaches are not “cures”, but they may offer safer and more practical ways to support brain health.
What families can do now
If you are concerned about a parent, partner or older relative, there are practical steps you can take now.
Encourage early assessment
Memory changes are not always Alzheimer’s.
A GP can help rule out:
- vitamin deficiencies
- thyroid problems
- medication side effects
- infections
- depression
Early support matters.
Focus on brain-healthy habits
Simple changes may help support cognitive function:
- regular exercise
- Mediterranean-style diet
- managing diabetes and blood pressure
- improving sleep
- staying socially connected
- reducing alcohol and smoking
Check nutritional status
It could be worth speaking to a GP or clinician about testing for:
- vitamin B12
- folate
- vitamin D
Nutrition can play a role in cognitive health.
Support emotional wellbeing
Living with memory loss can cause:
- anxiety
- frustration
- isolation
Supportive routines and reassurance matter for both the person and their family.
A balanced message for families
It is understandable to feel disappointed by the latest findings.
But this does not mean there is no hope.
The science around Alzheimer’s is evolving.
And while no treatment currently offers a cure, there is growing evidence that:
- early action matters
- prevention matters
- lifestyle matters
- support matters
For families caring for an older loved one, focusing on what can be done today may be more helpful than waiting for tomorrow’s breakthrough.
Even when medicine has limits, practical support and informed choices can still make a real difference.
Hand up! This article was written with the help of AI software ChatGTP. If you are worried about a loved one’s memory, the first step should always be to speak to your GP or a healthcare professional for personalised advice.
Image from Unsplash+